LeMaitre Vascular, Inc. (LMAT) — Fair Value Analysis

Base-case fair value (P50): $76.92 · Current price: $93.95 · Verdict: Overvalued

The Verdict on LMAT

Monte Carlo simulations indicate that LEMAITRE VASCULAR INC (LMAT) is currently Fairly Valued. With a median fair value (P50) of $76.92, our analysis suggests a -18.1% difference compared to LMAT's present trading price of $93.95. This outcome, derived from extensive scenario modeling, places the stock firmly within its appropriate valuation range, reflecting its operational and financial health. The minor divergence between the current market price and our P50 fair value further solidifies the Fairly Valued assessment, suggesting that the market has largely absorbed available information.

How LMAT stacks up against peers

LMAT's Fairly Valued status aligns with its average quality tier, reflecting its operational and financial health relative to sector peers. While the company's current price of $93.95 is slightly above our P50 estimate of $76.92, this difference is not significant enough to warrant an "overvalued" rating, given its fundamental standing. The average quality tier implies a balanced risk-reward profile, suggesting that LMAT performs adequately within its industry. This consistency between fundamental quality and fair value derived from our simulations underpins the Fairly Valued verdict, providing a realistic picture of the stock's current standing.

What this means for investors

For investors analyzing LMAT, the Fairly Valued verdict, supported by a median fair value of $76.92 and a current price of $93.95, suggests that the market is largely pricing in the company's average operational and financial health. The -18.1% difference against our P50 indicates limited immediate arbitrage potential based solely on this fair value assessment. While a downside scenario is always possible, the current valuation, corroborated by the average quality tier, does not flag LMAT as significantly mispriced. FairCurve's detailed Monte Carlo analysis helps to contextualize this valuation, providing a comprehensive view of potential outcomes. To see the full bear and bull distribution and track LMAT's fair value as new fundamentals are released, sign up for a free FairCurve account.